TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
LinkoCare Life Sciences AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
286
|
1,489
|
0 |
Financial expenses |
20
|
46
|
13 |
Earnings before taxes |
-4,280
|
-1,563
|
-3,140 |
EBITDA |
-4,193
|
-1,376
|
-2,927 |
Total assets |
1,638
|
2,153
|
766 |
Current assets |
1,588
|
2,042
|
506 |
Current liabilities |
716
|
359
|
368 |
Equity capital |
922
|
1,793
|
398 |
- share capital |
51
|
47
|
49 |
Employees (average) |
4
![]() |
4
![]() |
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.3%
|
83.3%
|
52.0% |
Turnover per employee |
72
|
372
|
0 |
Profit as a percentage of turnover |
-1496.5%
|
-105.0% | |
Return on assets (ROA) |
-260.1%
|
-70.5%
|
-408.2% |
Current ratio |
221.8%
|
568.8%
|
137.5% |
Return on equity (ROE) |
-464.2%
|
-87.2%
|
-788.9% |
Change turnover |
-1,309
|
1,489
|
-10 |
Change turnover % | -82% | -100% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.